Fiduciary Trust’s Insmed INSM Stock Holding History

Fiduciary Trust’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,389	Closed	-$227K	–	913
2026 Q1	$227K	Buy	+1,389	New	+$214K	﹤0.01%	811
2025 Q3	–	Sell	-5,296	Closed	-$533K	–	861
2025 Q2	$533K	Sell	5,296 -1,033	-16%	-$79K	0.01%	525
2025 Q1	$483K	Buy	+6,329	New	+$484K	0.01%	525

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Fiduciary Trust's INSM Position: Q2 2026 in Review

Fiduciary Trust sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,389 shares — an estimated $227K sold.

Fiduciary Trust first reported a position in INSM in Q1 2025 and held it in 3 quarters. The position peaked at $533K in Q2 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Fiduciary Trust reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Fiduciary Trust sold 1,389 Insmed shares in Q2 2026, an estimated $227K.
Fiduciary Trust first reported a position in Insmed in Q1 2025 and held it in 3 quarters.
Fiduciary Trust's Insmed position peaked at $533K in Q2 2025.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.